Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,085 | -44,605 | -25,977 | -65,715 | 48,354 |
| Depreciation Amortization | 243 | 166 | 86 | 221 | 153 |
| Accounts receivable | -756 | 278 | 487 | 1,915 | 2,145 |
| Other Working Capital | -2,127 | 4,902 | 907 | 8,064 | 4,874 |
| Other Operating Activity | 4,959 | 2,737 | 1,304 | 2,338 | -96,070 |
| Operating Cash Flow | $-57,766 | $-36,522 | $-23,193 | $-53,177 | $-40,544 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -27,500 | -27,500 | -8,500 | -17,000 | -8,000 |
| PPE Investments | -398 | -328 | -122 | -1,485 | -1,133 |
| Purchase Of Investment | -1,012 | -1,012 | -1,012 | -22,839 | -18,191 |
| Sale Of Investment | 66,255 | 44,151 | 29,642 | 79,079 | 57,314 |
| Investing Cash Flow | $37,345 | $15,311 | $20,008 | $37,755 | $29,990 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 92,362 | 16,981 | N/A | 161 | 145 |
| Other Financing Activity | 0 | 0 | 0 | -21 | -21 |
| Financing Cash Flow | $92,362 | $16,981 | $N/A | $140 | $124 |
| Exchange Rate Effect | -20 | -24 | -1 | 48 | 29 |
| Beginning Cash Position | 16,206 | 16,206 | 16,206 | 31,440 | 31,440 |
| End Cash Position | 88,127 | 11,952 | 13,020 | 16,206 | 21,039 |
| Net Cash Flow | $71,921 | $-4,254 | $-3,186 | $-15,234 | $-10,401 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,766 | -36,522 | -23,193 | -53,177 | -40,544 |
| Capital Expenditure | -408 | -328 | -122 | -1,518 | -1,159 |
| Free Cash Flow | -58,174 | -36,850 | -23,315 | -54,695 | -41,703 |